Monday, August 15, 2022

Eye doctors who get even small payments from drug companies more likely to prescribe name-brand eyedrops


 News Release 15-Aug-2022
As little as $65 per year appears to influence practitioners
Peer-Reviewed Publication
Johns Hopkins Medicine


In a lookback study of prescribing patterns among thousands of American ophthalmologists and optometrists, Johns Hopkins Medicine researchers concluded that eye doctors who receive even small financial incentives from pharmaceutical companies, such as free food, sponsored travel to attend meetings or consulting fees, are up to twice as likely to prescribe the companies’ brand name eyedrops for glaucoma instead of cheaper generic versions.



No comments:

Post a Comment